Nicole Rioles

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Animas LLC manufactures and distributes external insulin pumps for diabetes patients. The company was founded on November 5, 1996 and is headquartered in West Chester, PA.

AgaMatrix, Inc. develops and manufactures medical devices. It offers next generation blood glucose monitoring products for the diabetes market. The firm’s products include iBGStar Diabetes Manager and Zero-Click software. The company was founded by Sridhar G. Iyengar, Ian S. Harding and Sonny X. Vu in 2001 and is headquartered in Salem, NH.

Fargo Ta LLC design and manufactures audio products. It offers table radios, bluetooth streaming, portable radios, special collections, internet radios, Hi-Fi systems, and clock radios. The company was founded by Thomas J. DeVesto on July 10, 2000 and is headquartered in Boston, MA.

PointCare Technologies, Inc. develops, manufactures and markets medical diagnostic products. It offers PointCare NOW, an analyzer and reagent system for diagnostic management of HIV/AIDS patients at the point-of-care, CD4NOW Reagent Kit 100, an analyzer and reagent system. The company was founded by Petra B. Krauledat and Peter W. Hansen in 2003 and is headquartered in Marlborough, MA.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

Senscio Systems, Inc. develops digital health solutions that provide information and support for consumers and clinicians. It offers Ibis solution, which provides a clinical safety net that enables care in the least restrictive setting for people with complex clinical, social, and behavioral conditions. The firm’s Ibis recognizes emerging health issues and care gaps in real time, provides self-care protocols, and alerts the care team to early intervention opportunities, avoiding the need for hospitalization using patent-pending artificial intelligence. The company was founded by Pilai De, Hugh Franklin Stoddart and Hugh A. Stoddart in 2010 and is headquartered in Boxborough, MA.

Songbird Holdings LLC designs and manufactures hearing devices. Its products include songbird ultra, songbird ultra 2.0 replacement batteries, 2-pack ultra 2.0 right ear assembly and songbird air. The firm offers its products online, as well as through retailers. Songbird makes it as easy as buying a pair of new reading glasses. It provides a strong alternative to traditional hearing aids that can cost thousands of dollars. The company was founded in 2000 by Frederick J. Fritz and is headquartered in Tulsa, OK.

The Charles Stark Draper Laboratory, Inc. engages in the design, development, and deployment of technological solutions. It focuses on the areas of commercial, space, national security, strategic systems, and global challenges. It provides engineering services to government, commercial companies, and educational institutions. The company was founded by Charles Stark Draper in 1934 and is headquartered in Cambridge, MA.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

Part of Pfizer Inc., Wyeth BioPharma is a company that develops and manufactures protein biopharmaceuticals. The company is based in Collegeville, PA.

Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA.

Pittsburgh Life Sciences Green House (PLSG) is a venture capital firm founded in 2002. The firm is headquartered in Pittsburgh, Pennsylvania.

Protein Technologies, Inc. engages in the design, manufacture and supply of solid phase synthesizers. The company was founded in 1985 and is headquartered in Tucson, AZ.

Massachusetts Life Sciences Center functions as a pension/retirement fund. The private company is based in Waltham, MA. The CEO of the company is Kenn Turner.

Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA.

ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA.

Alertgy, Inc. engages in the development of a device for diabetes. Its product, Alerty GM, is a wristband that works with a mobile application to measure blood sugar. The company was founded by Marc E. Rippen and is headquartered in Melbourne, FL.

Unitio, Inc. operates a platform for the healthcare industry.

Rheos Medicines, Inc. operates as a biopharmaceutical firm. It develops novel medicines that modulate metabolic pathways in immune cells to treat disease. The company was founded by Erika Pearce, Edward Pearce, Laurence Turka, Richard Flavell, Ken Smith, and E. William St. Clair and is headquartered in Cambridge, MA.

Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA.

Theromics, Inc. is a medical device technology company that is developing a next-generation thermal accelerant technology for soft tissue ablation procedures and combination therapy. The company is based in West Bridgewater, MA. The company's proprietary heatsync™ gel is based on a protein naturally found in the body and may increase cost-efficiencies and improve outcomes through more focused and patient-centric delivery. The company will first focus on tumor ablations and then expand into additional applications, including pain and abnormal uterine bleeding. Longer-term, Theromics plans to apply its thermal technology for use as an oncolytic intratumoral drug/immunotherapy delivery platform with the potential to enhance efficacy and improve safety profiles of currently approved medicines. The company was founded by Damian E. Dupuy, William Keun Chan Park. The CEO is Ron Murphy.

Maroon Venture Partners LLC (Maroon Venture Partners) is a venture capital firm founded in 2016. The firm is headquartered in Amherst, Massachusetts.

L-Nutra, Inc. develops nutri-technologies that mimic the effects of fasting, to enhance the body?s natural ability to rejuvenate itself and promote longevity. The company was founded by Valter Longo and is headquartered in Los Angeles, CA.

Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022.

Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer.

Altrixbio, Inc. develops novel drugs that target metabolic diseases. The company is based in Cambridge, MA. The company was founded in 2019 by Ali Tavakkoli, Jeffrey Karp, Nancy Briefs. Nancy Briefs has been the CEO since 2019.

Basys.Ai LLC is a healthcare platform that utilizes generative AI to simplify prior authorization and utilization management. The platform promotes transparency and collaboration among healthcare insurers, providers, and other stakeholders to reduce administrative and medical costs and improve healthcare outcomes. The American company was founded by Amber Nigam and Jie Sun, with Amber Nigam serving as CEO since incorporation.

Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts.